CELLIANT® WITH
REPREVE®
CELLIANT with REPREVE marries CELLIANT infrared technology with REPREVE’s rPET sustainable fibers made from recycled plastic bottles and pre-consumer waste in a new solution that is better for you, and better for the earth.
RECYCLED ENERGY MEETS RECYCLED FIBER
CELLIANT is tested and proven to work with REPREVE, the global leader in recycled performance fibers. Leveraging its proprietary regeneration technology, REPREVE has transformed more than 35 billion plastic bottles into recycled fiber that delivers enhanced comfort, greater performance, and superior durability. As the only eco-performance fiber with U TRUST® product verification to certify transparency and traceability, REPREVE empowers brands and consumers to champion sustainability.
AMPLIFY YOUR PRODUCTS
CELLIANT differentiates your brand’s products by embedding natural minerals into fibers, yarns, and fabrics to create infrared textiles that promote local circulation and cell oxygenation while helping keep the body at the right temperature.
UNLIMITED APPLICATIONS
Both CELLIANT and REPREVE are key ingredients in world-class brands across many sectors, from apparel and sportswear to upholstery fabric and bedding. Anywhere brands want trusted sustainability plus infrared wellness to set their products apart can now request CELLIANT with REPREVE.
LOCAL MANUFACTURING
CELLIANT with REPREVE’s official preferred North America knitting partner is Beverly Knits, who also operates Creating Dyeing & Finishing, LLC. The three-way partnership allows for the production of finished goods to take place within a 300-mile radius, from CELLIANT mineral processing to final product.
SCIENTIFICALLY VALIDATED
The CELLIANT Science Advisory Board works with primary investigators to rigorously test and validate the science of infrared and its benefits. This includes experts in photobiology, nanotechnology, sleep medicine, human physiology, diabetes, and wound care. To date, there have been 9 peer-reviewed published studies.
AWARD WINNING
TECHNOLOGY
CONTACT
STAY CONNECTED
The FDA determined products containing CELLIANT® are medical devices because they are intended to temporarily increase blood flow and local circulation at the site of application in healthy individuals.
The FDA has determined that CELLIANT® products are medical devices as defined in section 201(h) of the Federal Food, Drug and Cosmetic Act and are general wellness products.
The FDA has not approved or designated CELLIANT® products for any purpose and has not made any determination about, or endorsement of, its stated use or benefits.
The FDA has determined that CELLIANT® products are medical devices as defined in section 201(h) of the Federal Food, Drug and Cosmetic Act and are general wellness products.
The FDA has not approved or designated CELLIANT® products for any purpose and has not made any determination about, or endorsement of, its stated use or benefits.
As part of the 513(g) submission process, the FDA reviewed and commented on appropriate health and wellness claims for CELLIANT products.
CELLIANT® is designated as a Class 1 Medical Device in Australia, Canada, the European Union, Japan, New Zealand, the United Arab Emirates and the United Kingdom. CELLIANT® is cleared to market in China, India, Indonesia, Korea, Malaysia, Mexico, Peru, Philippines, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand and Vietnam, with more countries and regions to follow.
For more information on the FDA classification of a medical device, visit the U.S. FDA site.
CELLIANT® is designated as a Class 1 Medical Device in Australia, Canada, the European Union, Japan, New Zealand, the United Arab Emirates and the United Kingdom. CELLIANT® is cleared to market in China, India, Indonesia, Korea, Malaysia, Mexico, Peru, Philippines, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand and Vietnam, with more countries and regions to follow.
For more information on the FDA classification of a medical device, visit the U.S. FDA site.
